CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review. Am. J. Med. Sci. Innov. [Internet]. 2023 Jul. 31 [cited 2026 May 8];2(2):44-56. Available from: https://e-pallipublishers.com/index.php/ajmsi/article/view/1760